SYNTHESIS AND ASSEMBLY OF FUNCTIONALLY ACTIVE HUMAN VASCULAR ENDOTHELIAL GROWTH-FACTOR HOMODIMERS IN INSECT CELLS

被引:64
作者
FIEBICH, BL
JAGER, B
SCHOLLMANN, C
WEINDEL, K
WILTING, J
KOCHS, G
MARME, D
HUG, H
WEICH, HA
机构
[1] UNIV FREIBURG, INST MOLEC CELL BIOL, MOOSWALDALLEE 1-9, W-7800 FREIBURG, GERMANY
[2] UNIV FREIBURG, GODECKE AG, INST MOLEC CELL BIOL, W-7800 FREIBURG, GERMANY
[3] UNIV FREIBURG, INST ANAT, W-7800 FREIBURG, GERMANY
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 1993年 / 211卷 / 1-2期
关键词
D O I
10.1111/j.1432-1033.1993.tb19865.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vascular endothelial growth factor (VEGF) is an angiogenic growth factor with a target-cell specificity highly restricted to vascular endothelial cells. Recombinant baculovirus were constructed for the production of two different forms of the human VEGF protein in insect cells. VEGF165 and VEGF121 proteins produced by Sf158 cells under went a similar processing compared with mammalian cells, including efficient glycosylation, formation of a disulfide-linked dimer and secretion into the media. Only one of these forms, VEGF165 had a high affinity for heparin and this characteristic was used to purify this form to homogenicity by a two-step heparin-affinity chromatography. The biological activity of the purified 43-kDa homodimer was demonstrated by high-affinity binding to VEGF receptors, and by the induction of DNA synthesis in vascular endothelial cells. A positive angiogenic activity in vivo was demonstrated by the day-13 chorioallantoic-membrane assay. The mitogenic potency of VEGF121 for human umbilical vein endothelial cells was very similar compared to VEGF165. These results demonstrate that an angiogenic growth factor whose normal processing requires glycosylation and disulfide-bridge formation can be efficiently expressed in high concentration (up to 5 mug/ml) in insects cells.
引用
收藏
页码:19 / 26
页数:8
相关论文
共 41 条
  • [1] VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) GENE IS EXPRESSED DIFFERENTIALLY IN NORMAL-TISSUES, MACROPHAGES, AND TUMORS
    BERSE, B
    BROWN, LF
    VANDEWATER, L
    DVORAK, HF
    SENGER, DR
    [J]. MOLECULAR BIOLOGY OF THE CELL, 1992, 3 (02) : 211 - 220
  • [2] BREIER G, 1992, DEVELOPMENT, V114, P521
  • [3] CHEN CA, 1988, BIOTECHNIQUES, V6, P632
  • [4] TUMOR VASCULAR-PERMEABILITY FACTOR STIMULATES ENDOTHELIAL-CELL GROWTH AND ANGIOGENESIS
    CONNOLLY, DT
    HEUVELMAN, DM
    NELSON, R
    OLANDER, JV
    EPPLEY, BL
    DELFINO, JJ
    SIEGEL, NR
    LEIMGRUBER, RM
    FEDER, J
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (05) : 1470 - 1478
  • [5] VASCULAR-PERMEABILITY FACTOR - A UNIQUE REGULATOR OF BLOOD-VESSEL FUNCTION
    CONNOLLY, DT
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1991, 47 (03) : 219 - 223
  • [6] LIGAND RECEPTOR INTERACTIONS INVOLVED IN THE STIMULATION OF SWISS 3T3 FIBROBLASTS BY INSULIN-LIKE GROWTH-FACTORS AND INSULIN
    CORPS, AN
    BROWN, KD
    [J]. BIOCHEMICAL JOURNAL, 1988, 252 (01) : 119 - 125
  • [7] DVORAK HF, 1981, LYMPHOKINE REP, V2, P203
  • [8] Ferrara N, 1991, Growth Factors, V5, P141, DOI 10.3109/08977199109000278
  • [9] FERRARA N, 1991, METHOD ENZYMOL, V198, P391
  • [10] PITUITARY FOLLICULAR CELLS SECRETE A NOVEL HEPARIN-BINDING GROWTH-FACTOR SPECIFIC FOR VASCULAR ENDOTHELIAL-CELLS
    FERRARA, N
    HENZEL, WJ
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 161 (02) : 851 - 858